OPEN LETTER AND NOTICE OF LIABILITY FROM DOCTORS AND SCIENTISTS

TO THE EMA AND THE MEMBERS OF THE EUROPEAN PARLIAMENT

REGARDING COVID-19 VACCINATION

<<Name>>

September 13, 2021

This Notice of Liability has been SERVED to you personally.

In March 2021, we alerted you and the world to the fact that the approval of the so-called gene-based
COVID-19 vaccines was premature and reckless, and that their administration constituted human
experimentation in violation of the Nuremberg Code. Our concerns regarding the potential dangers of
experimental agents were founded on common textbook knowledge of immunobiology and medicine.
Simple reasoning led to the foresight that administration of the agents would incur multifaceted
pathological events leading, among others, to life-threatening thromboembolic events. You were called
upon to suspend the vaccination program until these concerns had been tended to in a satisfactory
manner.

This request was scorned and the vaccination program has been rolled out on a global scale, with
catastrophic consequences that we trust are known to you. Our original fears have been confirmed and
further pathways leading to injury and death by the experimental agents have been uncovered through
new scientific discoveries in 2021. The rush to vaccinate first and research later has left you in a
position whereby COVID-19 vaccination policy is now entirely divorced from the relevant evidence-
base.

The current state-of-the-tragedy is summarized in the appended document.

As you consider your next steps in mandating a vaccine that is contra-indicated by science, we draw
your attention to recently published Freedom of Information requests, which reveal gross negligence in
the COVID vaccine authorisation process, including misleading the Commission on Human Medicines
as to whether any independent verification of vaccine trial data had occurred.

Hapless and defenceless children are now becoming victims of the blasphemic and negligently
regulated vaccination agenda. We charge you for actively or tacitly paving the way to the second
holocaust of mankind. The same charge has been independently submitted by survivors of the first
holocaust and their families.

You are hereby placed on notice that you stand to be held personally and individually responsible for
causing foreseeable and preventable harm and death from COVID-19 vaccines, and for supporting
crimes against humanity, defined as acts that are purposely committed as part of a widespread or
systematic policy, directed against civilians, committed in furtherance of state policy.

The gravity of your deeds is now laid out before the world. For the sake of yourselves and your
families, rise and respond. Or go down in history books in indelible shame and disgrace.
Signed,
Doctors for Covid Ethics

Cc: Rechtsanwaltskanzlei Dr. Reiner Fuellmich

 The Dangers of Covid-19 Booster Shots and Vaccines: Boosting
Blood Clots and Leaky Vessels

New discoveries in the immunology of SARS-CoV-2 and COVID-19 vaccines

1. Summary: Are COVID vaccines and booster shots safe and necessary? New discoveries in SARS-
CoV-2 immunity and vaccine-immune interactions.
2. In Full: Explanation of new findings on the immunology of COVID-19 and its vaccines: How and
why Covid-19 vaccines incite immunological attack on blood vessel walls. What is wrong with
booster shots?
3. Implications for doctors and patients.

1. Summary: Are COVID Booster Shots and Vaccines Safe and

Necessary? New Discoveries in SARS-CoV-2 Immunity and
Vaccine-Immune Interactions
By now, most people have heard that COVID-19 vaccines can cause blood clotting and bleeding. Some
readers may even be aware that reports of death following COVID-19 vaccination outnumber those for all
vaccines combined since records began, 31 years ago, in the official US database VAERS [1,2].
With many patients now having received their first and second doses of COVID-19 vaccines, additional
booster shots are being rolled out in many countries. Given that no clinical trials have been performed on
more than two injections of any vaccine, it is important that doctors and patients understand how the
vaccines interact with the immune system, and the implications for booster shots.
So far, doctors and patients confronted with information on COVID vaccine side effects are typically
reassured that the benefits of COVID-19 vaccination outweigh the risks. Governments, the pharmaceutical
industry, regulators and the media advise populations that the majority of adverse events are mild and
transient, with serious complications in only a small minority of vaccine recipients.
Most patients, however, are unaware that among relevant scientific experts such a view is not so readily
shared. Eminent independent scientists and researchers in the fields of immunology and microbiology
have been writing to medical regulators since early 2021 [3], warning of vaccine-related blood clotting
and bleeding, including that the official data on blood abnormalities post-vaccination likely represent “just
the tip of a huge iceberg” [4]. Those scientists’ warnings pre-dated vaccine suspensions around the world
due to acute disease from aberrant blood clotting post-vaccination. The warnings were based on
established immunological science, applied to the novel mechanism of action of the gene-based COVID-
19 vaccines.
Now, more than six months later, new discoveries in the immunology of SARS-CoV-2 [5] have caught up
with the rushed vaccination schedule, confirming and extending the experts’ prior warnings. The good
news is that we are more comprehensively protected against COVID-19 by our own pre-existing
immunity than was previously understood. On the other hand, this pre-existing immunity aggravates the
risk that COVID-19 vaccines will induce blood clotting and/or leaky blood vessels. This risk must be
expected to escalate with each revaccination. Vaccine-induced harm to our blood vessels is unlikely to be
rare.
Perhaps the most pertinent finding is that, due to the discovery of a widespread memory-type antibody
response to SARS-CoV-2, the antibodies induced by the COVID-19 vaccines can be expected to activate
the so-called complement system. This can bring about the destruction of any cell that manufactures the
SARS-CoV-2 spike protein, particularly in the circulation. If that happens to the endothelia, that is, the cell
layer that lines the inner surfaces of our blood vessels, then those vessels may begin to leak [6] and clots
will form. Given that 2021 research showed the spike protein to enter the bloodstream shortly after
vaccination [5], this dangerous endothelial involvement in spike-production is highly likely, and should be
expected to occur.
As stark as these medical realities may be, the silver lining is that the same antibody profile, along with
previously documented T-cell immunity [7–11], protects around 99% of the population against life-
threatening SARS-CoV-2 infections. This ties in with the known fact that over 99% of people are safe
from death with COVID-19 [12–14]. The implications for doctors and patients are that:
1. Vaccination against COVID-19 is unnecessary. Populations are protected by their immune systems
against COVID-19. This applies to SARS-CoV-2 in all its variants.
2. Booster shots are uniquely dangerous, in a way that is unprecedented in the history of vaccines.
This is because repeatedly boosting the immune response will repeatedly boost the intensity of
self-to-self attack.
An important consideration for patients is that those who have already been vaccinated against COVID-
19, and whose health remains intact, can protect themselves against serious harm by stopping now.
For a detailed explanation of the science behind these vaccine-immune interactions, please read Part II.
Implications for doctors and patients are considered in Part III.

2. In Full: Explanation of New Findings on the Immunology of

SARS-CoV-2 and COVID-19 Vaccines

2.1. How and why COVID-19 vaccines incite immunological attack on blood
vessel walls. What is wrong with booster shots?
Until recently, the immune profile of COVID-19 and COVID-19 vaccines was not fully characterised.
While we have known since mid-2020 that robust and lasting memory T-cell immunity to SARS-CoV-2
exists [7–11], the antibody picture has been less clear. Now, however, a convergence of evidence from
peer reviewed studies published in 2021 reveals that pre-existing immunity to SARS-CoV-2 involves not
only T-cells but also memory antibodies, in 99% of people studied. Two publications from 2020 alert to
the probability that the immune response to the vaccine will also involve an important and powerful
component called the complement system. This has profound consequences for the risk-benefit analysis of
the vaccines.
Key papers behind these recent developments are:
1. Ogata et al. [15] showing that the SARS-CoV-2 spike protein circulates in the bloodstream shortly
after vaccination with mRNA vaccine. This constitutes compelling evidence that spike protein
molecules are produced by cells that are in contact with the bloodstream. The endothelial cells
lining blood vessel walls naturally represent prime candidates.
 2. Amanat et al. [16], Ogata et al. [15], and Wisnewski et al. [17], who found that circulating SARS-
CoV-2-specific IgG and IgA antibodies became detectable within 1-2 weeks after mRNA
vaccination. This early response indicates immunological memory—it can only be elicited through
re-stimulation of pre-existing immune cells.
3. Gallais et al. [18], who provided data consistent with a memory-type antibody response in over
99% of people studied following first contact with the SARS-CoV-2 virus.
4. Wisnewski et al. [17], who reported a very rapid increase of spike protein antibodies after the
second injection of mRNA vaccines. This finding underscores the immediate dangers of
revaccination.
5. Magro et al. [19,20] showing that following entry into the bloodstream, spike protein directs
complement attack to the inner vessel lining, causing damage and leakiness of the blood vessels
An explanation of the underlying immunology for laypeople follows.

2.2. Updated Immune Profile of COVID-19 and its Vaccines

Importantly for COVID-19 vaccination, the 2021 discoveries reveal that the SARS-CoV-2 virus
responsible for COVID-19 is not truly new to our immune systems. The finding that the overwhelming
majority of people show a memory-type antibody profile to COVID-19 vaccines proves that our immune
systems have seen viruses similar to SARS-CoV-2 before. As a result, our bodies have stored an immune
memory of that family of viruses, equipping us to fight back more rapidly and powerfully the next time
we encounter a similar virus again. As SARS-Cov-2 is of the coronavirus family, this indicates that we
possess lasting cross-immunity from previous exposure to other coronaviruses, such as common cold
coronaviruses, which are in wide circulation globally. Simply put, almost anyone who is fundamentally
healthy—or ‘immunocompetent’—is naturally sufficiently protected against COVID-19.
This immunological status accords with the well-documented reality that the infection fatality rate for
COVID-19 is 0.15-0.2% worldwide [12–14]. As is well known, COVID-19 infection runs a fatal course
only in those who are weakened by age and significant comorbidity. Put differently, once infected,
COVID-19 is non-lethal to >99.8% of the world’s population. This same figure is upwards of 99.9% in the
young and middle-aged. These statistics reflect the fact that protective cross-immunity is the global norm.

2.3. A Word on “Cases”

But what about the second and third waves of “cases”, including from Delta and other variants, around the
world?
It is important to understand that a COVID-19 “case”, as currently defined, does not correspond to being
ill. To an unprecedented extent in medical history, rather than referring to actual disease, the term “case”
has become conflated with nothing more than a positive Polymerase Chain Reaction (PCR) test result.
While PCR tests are useful in laboratory research and as diagnostic tools when carefully performed, they
are not reliable or appropriate when used in isolation, nor set at extremely high sensitivities, nor in poorly
trained hands, as has been the case overwhelmingly for COVID-19.
It has long been known that reliance on PCR tests alone to define medical “cases” and causes of death
results in “overdiagnosis, overtreatment, and increased health care costs” [21]. If PCR alone were used to
diagnose an infection with the diarrhoeal pathogen Clostridium difficile (CD), for instance, an epidemic of
CD would immediately appear. We would find, based on PCR results, that 50% of people in long term
care, and 15% of those hospitalised for any reason, are CD “cases” [22]. Should they die of any cause
following a positive PCR test for CD, they would be recorded as “dying with” CD. That figure could
conceivably approach 100% if PCR tests were performed at the high sensitivities, or cycle thresholds,
routinely employed when testing for COVID-19, in which the sensitivity of the test has been dialled up to
meaningless extremes [23].
Moreover, even if we accepted PCR alone as a diagnostically appropriate tool—and therefore the high
number of “cases” that it generates—we would still necessarily infer a very low infection fatality rate for
COVID-19. This supports rather than contradicts the reality that SARS-CoV-2 poses no significant threat
to the immunocompetent. In short, thanks to population immunity, for the vast majority of us, a “case”
does not equate to severe disease.

2.4. Four Immunological Problems with COVID-19 Vaccines

While the now clearly established widespread cross-immunity against SARS-CoV-2 implies that most of
us are safe from severe COVID-19 disease, it also means that we are vulnerable to the harms of gene-
based vaccines. Due to recall immunity against the virus, vaccination will cause our immune systems to
fight aggressively against not only the SARS-CoV-2 spike protein, but against ourselves. This deleterious
autoimmune attack must be expected to intensify with each repeated injection.
The COVID-19 vaccine technology’s interaction with the immune system creates the following four
specific problems:
1. Flying under the immune system’s radar with the vaccine’s genetic code
2. Delivering the spike protein into the bloodstream
3. Inducing immune attack on the blood vessel lining
4. Enhancing the severity of natural infection

2.4.1. Flying Under the Immune System’s Radar with the Vaccine’s Genetic Code
To understand why COVID-19 vaccine technology is dangerous, it is necessary to first understand how
the gene-based vaccines differ from traditional vaccination methods.
A conventional viral vaccine can be a live virus strain derived from the pathogenic virus that has been
attenuated through one or more genetic mutations, or it can consist of chemically inactivated virus
particles that are no longer able to infect any cells. In both cases, protein antigens will be exposed on the
surface of the vaccine particles, which can be recognized by antibodies once these have been formed.
COVID-19 vaccines, on the other hand, are not protein antigens but the genetic blueprint for the SARS-
CoV-2 spike protein antigen. That blueprint comes in the form of mRNA or DNA, which, after
vaccination, enters our body’s cells and instructs those cells to manufacture the spike protein. The spike
protein then protrudes from the cell and induces antibody formation. In response, the immune system will
react not only with the spike protein, but will attack and try to destroy the entire cell.
If we are injected with a traditional live virus vaccine to which we have no immunity, then these vaccine
virus particles will also infect some of our body cells and propagate within them. Two kinds of immune
reactions will then occur:
1. Cytotoxic T-lymphocytes (killer T-cells) (see section 2.4.3.1) that recognize viral protein fragments
associated with the infected cells will proliferate, attack, and destroy the infected cells.
2. B-lymphocytes that recognize viral proteins (see section 2.4.3.2) will proliferate and start
producing antibodies—soluble protein molecules that can recognize and neutralize virus particles.
This immune reaction will in principle resemble that to an infection with the corresponding wild-type
virus. It will be milder, since the vaccine strain of the virus has been attenuated; however, some cells will
get destroyed in the process, which may sometimes cause functional organ damage. Live virus vaccines
therefore tend to be more prone to adverse reactions than are inactivated virus vaccines.
Now, a key point to note is that if we inject a live traditional vaccine into a person who is already immune
—due to either a previous vaccination, or to prior infection with the corresponding wild-type virus—the
extent of cell destruction will be much reduced. Such a person will already have antibodies to the virus;
these will recognize the viral protein antigens and will bind and inactivate most of the vaccine virus
particles before they manage to infect a cell. Therefore, even though the killer T-cells may be all riled up,
they will not find very many infected cells to pounce on.
The crucial difference between a conventional live virus vaccine and a gene-based COVID vaccine—and
in particular an mRNA vaccine—is that the latter contains no protein antigens whatsoever; instead, it only
contains the blueprint for their synthesis inside the infected cells. Therefore, if such a vaccine is injected
into a person with antibodies and existing T-cell immunity, the vaccine particles will “fly under the radar”
of the antibody defence and reach our body cells unimpeded. The cells will then produce the spike protein,
and subsequently be destroyed and attacked by the killer T-cells. The antibodies, rather than preventing the
carnage, will join in by also binding to the cell-associated spike protein and directing the complement
system (see later) and other immune effector mechanisms against these cells. In a nutshell, pre-existing
immunity mitigates the risk of conventional vaccines, but it amplifies the risk of gene-based vaccines.
Importantly, before COVID, this risky gene-based vaccine technology had never before been used on a
wide scale against infectious disease and is inherently experimental. The COVID-19 vaccination program
is thus the largest human experiment ever performed in history.

2.4.2. Delivering the Spike Protein into the Bloodstream

A dire danger of COVID-19 vaccines is that spike proteins produced by myriad endothelial cells, i.e. the
innermost cells lining blood vessel walls, will be exported to the cell surface and protrude directly into the
bloodstream. Moreover, a fraction of these spikes will be cleaved during their passage to the outside
world. They will fall off the cells into the bloodstream and then bind to their receptors on other endothelial
cells at distant sites.
While at the outset of the vaccination campaign in 2020 it was unknown to what extent COVID vaccines
entered the bloodstream, human data from 2021 reveal that the spike protein shows up within the
circulation on the very day of the injection [15]. Similarly, animal studies submitted by Pfizer to the
Japanese government [24] found that the vaccine appears in the circulation within 15 minutes of
intramuscular injection, reaching maximum plasma concentration within just two hours. Very high levels
have subsequently been recorded in the liver, the spleen, the adrenal glands, and the ovaries. Vaccine
components have also been observed in the central nervous system (the brain and the spinal cord), albeit at
lower concentrations. Such widespread distribution throughout the body via the bloodstream is a feat that
the SARS-CoV-2 virus does not usually achieve.

2.4.2.1. Open Questions in the Ongoing Experiment

But how do COVID-19 vaccine particles enter the circulation in the first place? The vaccine is injected
intramuscularly, and the vaccine particles are too large to passively diffuse across blood vessel walls. Most
obviously, the vaccines will follow the conventional, relatively time-consuming path which takes them via
the draining lymph nodes to the blood circulation. But additionally, two possibilities for very rapid entry
into the bloodstream should be heeded. The first is via direct uptake by vessels that are damaged during
insertion of the needle. Secondly, it is possible that the vaccine particles undergo ‘transcytosis’, a process
that enables large molecules to be transported across intact cell layers. Whatever the case may be,
although Pfizer knew before the onset of clinical trials that their vaccine reached the bloodstream rapidly,
either they failed to file these findings with medical regulators in Europe, the US and other Western
countries, or the regulators failed to act upon the findings [25].
This is a critical oversight where patient safety is concerned. Given that the gene-based vaccines induce
the body’s cells to become immune targets, where in the body this takes place is of critical concern. While
immune-mediated cell death is never favourable, it is particularly detrimental and dangerous if it afflicts
the blood vessel walls.

2.4.3. Attacking the Vessel Walls: Clotting and Leaky Vessels

While all vaccines seek to stimulate an immune response, not all immune responses are created equal.
Some are safe and well-modulated whereas others can be misdirected and out of control. Immune
responses are problematic when they attack the self, as in autoimmune conditions, and/or when they are
excessively intense and severe.
COVID-19 vaccines incur problematic immunity in both key ways. First, they can be expected mobilise a
self-to-self immune response against the endothelial cells lining blood vessel walls. Second, by boosting
SARS-CoV-2 immunity, they can be expected to incite an increasingly aggressive response with each
administration of the vaccine.
To understand the realities of these processes it is necessary to first understand the basics of the underlying
immune response. There are three key components of the immune system relevant to risks from COVID-
19 vaccines: T-cells, antibodies and the complement cascade.

2.4.3.1. T-cells
Once the body’s cells have been infected with a virus, immune cells known as cytotoxic T-cells or T-killer
cells attack and destroy the infected cells. This prevents infected cells from replicating the virus and
spreading the infection throughout the body. After the initial battle with a certain pathogen is over, some
of the specifically adapted T-cells enter a state of dormancy to become memory T-cells. In case the same
virus is encountered again, these dormant T-cells can be swiftly reawakened and propagated to mount a
faster and more vigorous response next time. Known as a secondary or memory-type response, it will also
occur with viruses that are not exactly the same as the one initially encountered but sufficiently similar to
be recognised. This latter phenomenon is referred to as cross-immunity.
It has been known since mid 2020 that we are protected against SARS-CoV-2 by cross-reactive memory
T-cells [7–11]. As with antibodies, this is based on previous encounters with common cold coronaviruses,
and with the SARS virus in a small number of people. Such prior experience has been found to confer
“robust” [7] and lasting T-cell cross-immunity to COVID-19. T-cell memory for the SARS virus is known
to last at least 17 years [7], but it likely lasts a lifetime.

2.4.3.2. Antibodies
Before the new discoveries of 2021, scientists’ concerns about clotting and bleeding were based primarily
on the prediction that killer T-cells would attack spike-producing endothelial cells, causing lesions on
vessel linings and promoting blood clots. While this mechanism remains valid, we now know that a
memory-type antibody response will join the attack on the vessel walls as well.
Whereas killer T-cells attack their targets cell-to-cell, antibodies are proteins that exert their effect by
binding to signature structures on the pathogen’s surface, known as epitopes. Instead of destroying cells
directly, once attached to an epitope, antibodies help to defeat invaders by “calling out the cavalry” on
infected cells.
This leads to the second process by which cells coated with viral spikes will inadvertently come under
immune attack. “Calling out the cavalry” means that the antibodies attached to the unnaturally created
spikes will trigger activation of the complement system, which thereupon will mount a massive attack on
the endothelial cells.
Importantly for deciphering the recent discoveries on SARS-CoV-2 immunity, the first time that the
immune system encounters a new pathogen, new antibodies in a shape capable of binding to that
pathogen’s epitopes must be formed (by immune cells known as B-cells). First-time antibody production
is slow, taking approximately four weeks. Should the same pathogen or family of pathogens invade again,
however, memory-type antibodies are then manufactured more rapidly, within one to two weeks. This is a
cardinal sign that the immune system has seen that pathogen before.
Another defining feature of a memory antibody response concerns the order in which antibody sub-types
are produced. If a pathogen is new, IgM is the first type of antibody to arrive on the scene. It is followed
later by IgG and IgA. The next time the pathogen arrives, however, IgG and IgA will be the first to arrive,
indicating that the virus, or its relatives, have invaded before.
Importantly, this is precisely what we see with COVID-19.
Several research groups found in 2021 that upon first exposure to SARS-CoV-2, and following COVID-19
vaccination, the antibody response was characteristic of the memory type, due both to the timing and
nature of antibodies measured. [xv-xvii] As a result, we now know that our immune systems recognise
SARS-CoV-2 at first sight, even “on the slightest viral challenge” [5]. In other words, SARS-CoV-2 is not
a novel coronavirus after all.
With respect to variants and the need for booster shots, memory B-cells, like memory T-cells, can
recognise not only a specific virus, but a whole family of viruses bearing related epitopes. It is
unsurprising, therefore, that memory B-cells recognise SARS-CoV-2 from the common cold. With cross
immunity this robust, closer relatives of SARS-CoV-2 in the form of variants will pose no obstacle to our
antibody response. The rising “cases”, hospitalisations and deaths attributed to Delta and other variants are
therefore almost certainly driven by false positive PCR results and misclassification than by a true
increase in COVID-19 disease. Indeed, according to Public Health England data, the Delta variant is non-
lethal in those under 50, and less than half as lethal as earlier strains in older age groups [26].
But why haven’t circulating antibodies to SARS-CoV-2 been detected in populations before? The answer
is that neither the antibodies nor T-cells associated with a memory-type response circulate in the
bloodstream. Once they are no longer needed, they become dormant, existing as a memory alone. Unless
elicited by re-exposure to a virus, they remain invisible in the bloodstream. The dormant antibodies will,
however, be ready and waiting to re-activate and call out the cavalry on the spike protein, in the form of
the complement cascade.
 2.4.3.3. Complement
Recent findings indicate that complement activation is a serious concern with respect to COVID-19
vaccine-immune interactions.
In light of the newly characterised antibody response to SARS-CoV-2, when antibodies attach to spike-
producing endothelial cells on vessel walls following vaccine administration, activated complement
proteins can be expected attach to the endothelial cells, and perforate their cell membranes [27,28]. The
ensuing death of the endothelial cells will expose the tissue underneath the epithelium, which will initiate
two significant events. It will induce blood clotting, and will cause the vessel walls to leak [6]. This
pathogenic mechanism has been documented in biopsies taken from SARS-CoV-2-infected patients
[19,29]. Those studies have described a “catastrophic microvascular injury syndrome mediated by
activation of complement” [29] as part of the SARS-CoV-2 spike protein immune response. It is precisely
this immune response that COVID-19 vaccines seek to induce.
Such vaccine-immune interactions are consistent with adverse events involving visible capillary rupture
under the skin that have been documented and reported following COVID-19 vaccination [30–33].

2.4.3.4. Leaky Vessels—The Promise of Booster Shots

Given that booster shots repeatedly boost the immune response to the spike protein, they will
progressively boost self-to-self immune attack, including boosting complement-mediated damage to
vessel walls.
Clinically speaking, the greater the vessel leakage and clotting that subsequently occurs, the more likely
that organs supplied by the affected blood flow will sustain damage. From stroke to heart attack to brain
vein thrombosis, the symptoms can range from death to headaches, nausea and vomiting, all of which
heavily populate adverse reactions to COVID-19 vaccines [2].
As well as damage from leakage and clotting alone, it is additionally possible that the vaccine itself may
leak into surrounding organs and tissues. Should this take place, the cells of those organs will themselves
begin to produce spike protein, and will come under attack in the same way as the vessel walls. Damage to
major organs such as the lungs, ovaries, placenta and heart can be expected ensue, with increasing severity
and frequency as booster shots are rolled out.

2.4.4. Enhancing the Severity of Wild Coronavirus Infection

Finally, as with the Dengue virus and several other viruses [34], antibodies to coronaviruses can ultimately
aggravate rather than mitigate illness. This is called antibody-dependent enhancement of disease. The
underlying mechanisms remain to be elucidated but it is already clear that the net effects are severely
detrimental.
Attempts to develop vaccines to the original SARS virus, which is closely related to SARS-CoV-2,
repeatedly failed due to antibody-dependent enhancement of disease [35–37]. The vaccines induced
antibodies, but when the vaccinated animals were subsequently infected with the wild-type virus, they
became more ill than the unvaccinated animals, in some cases mortally so [38].

3. Implications for Doctors and Patients

Although vaccine manufacturers and regulators are aware of the risks of antibody enhancement of disease,
this possibility was not adequately addressed in the clinical trials on any of the COVID-19 vaccines. The
FDA noted that Pfizer, “identified vaccine-associated enhanced disease, including vaccine-associated
enhanced respiratory disease, as an important potential risk” [23]. The EMA similarly acknowledged that
“vaccine associated enhanced respiratory disease” was “an important potential risk… that may be specific
to vaccination for COVID- 19”.
Why neither regulator sought to exclude such dangers prior to emergency use authorisation is an open
question that all doctors and patients are entitled to ask. Why medical regulators failed to investigate the
finding that large vaccine particles cross blood vessel walls, entering the bloodstream and posing risks of
blood clotting and leaky vessels is yet another open question again.
The fact that vaccine rollout began before the immune profile of SARS-CoV-2 and COVID-19 vaccines
had been adequately delineated is symptomatic of a rushed and highly politicised approach to the approval
and regulation of COVID-19 vaccines. As is the lack of clinical trials investigating the safety of COVID-
19 booster shots.
In this context, it is up to doctors and patients to uphold the social contract of the doctor-patient
relationship, and take medical prudence and patient safety into their own hands.
The World Medical Association, Declaration of Geneva, Physician’s Pledge states [39]:
“The health and wellbeing of my patient will be my first consideration. I will maintain the utmost respect
for human life. I will practise my profession with conscience and dignity and in accordance with good
medical practice. I will respect the autonomy and dignity of my patient. I will not use my medical
knowledge to violate human rights and civil liberties, even under threat.”

References
1. Open VAERS, (2021) VAERS COVID vaccine data.
2. Open VAERS, (2021) All deaths reported to VAERS by year
3. Doctors for Covid Ethics, (2021) Doctors for COVID Ethics: letters.
4. Doctors for Covid Ethics, (2021) Rebuttal letter to European Medicines Agency from Doctors for
Covid Ethics, April 1, 2021.
5. Bhakdi, S. et al. (2021) Letter to Physicians: Four New Scientific Discoveries Regarding COVID-
19 Immunity and Vaccines—Implications for Safety and Efficacy.
6. Doctors for Covid Ethics, (2021) Leaky Blood Vessels: An Unknown Danger of COVID-19
Vaccination.
7. Le Bert, N. et al. (2020) SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS,
and uninfected controls. Nature 584:457-462
8. Tarke, A. et al. (2021) Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell
reactivity in infected or vaccinated individuals. Cell reports. Medicine 2:100355
9. Grifoni, A. et al. (2020) Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with
COVID-19 Disease and Unexposed Individuals. Cell 181:1489-1501.e15
10. Mateus, J. et al. (2020) Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed
humans. Science 370:89-94
11. Sekine, T. et al. (2020) Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or
Mild COVID-19. Cell 183:158-168.e14
12. Ioannidis, J.P.A. (2020) Infection fatality rate of COVID-19 inferred from seroprevalence data.
Bull. World Health Organ. -:BLT.20.265892
13. Ioannidis, J.P.A. (2020) Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic.
Eur. J. Clin. Invest. 50:x-x
14. Ioannidis, J.P.A. (2021) Reconciling estimates of global spread and infection fatality rates of
COVID‐19: An overview of systematic evaluations. Eur. J. Clin. Invest. 5:e133554
15. Ogata, A.F. et al. (2021) Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of
mRNA-1273 Vaccine Recipients. Clin. Infect. Dis. -:x-x
16. Amanat, F. et al. (2021) SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies
to NTD, RBD and S2. Cell -:x-x
17. Wisnewski, A.V. et al. (2021) Human IgG and IgA responses to COVID-19 mRNA vaccines. PLoS
One 16:e0249499
18. Gallais, F. et al. (2021) Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune
Response without Seroconversion. Emerg. Infect. Dis. 27:x-x
19. Magro, C.M. et al. (2020) Docked severe acute respiratory syndrome coronavirus 2 proteins within
the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe
coronavirus disease 2019. Hum. Pathol. 106:106-116
20. Magro, C.M. et al. (2021) Severe COVID-19: A multifaceted viral vasculopathy syndrome. Annals
of diagnostic pathology 50:151645
21. Polage, C.R. et al. (2015) Overdiagnosis of Clostridium difficile Infection in the Molecular Test
Era. JAMA internal medicine 175:1792-801
22. Anonymous, (2021) Overdiagnosis of Clostridium difficile.
23. Palmer, M. et al. (2021) Expert evidence regarding Comirnaty (Pfizer) COVID-19 mRNA Vaccine
for children.
24. Anonymous, (2020) SARS-CoV-2 mRNA Vaccine (BNT162, PF-07302048) 2.6.4 Summary
statement of the pharmacokinetic study [English translation].
25. Palmer, M. and Bhakdi, S. (2021) The Pfizer mRNA vaccine: Pharmacokinetics and Toxicity.
26. Public Health England, (2021) SARS-CoV-2 variants of concern and variants under investigation
in England.
27. Bhakdi, S. and Tranum-Jensen, J. (1978) Molecular nature of the complement lesion. Proc. Natl.
Acad. Sci. U. S. A. 75:5655-5659
28. Tranum-Jensen, J. et al. (1978) Complement lysis: the ultrastructure and orientation of the C5b-9
complex on target sheep erythrocyte membranes. Scandinavian journal of immunology 7:45-6
29. Magro, C. et al. (2020) Complement associated microvascular injury and thrombosis in the
pathogenesis of severe COVID-19 infection: A report of five cases. Transl Res 220:1-13
30. Greinacher, A. et al. (2021) Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N. Engl. J. Med. -:x-x
31. Lee, E. et al. (2021) Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Am. J. Hematol. -:x-x
32. Malayala, S.V. et al. (2021) Purpuric Rash and Thrombocytopenia After the mRNA-1273
(Moderna) COVID-19 Vaccine. Cureus 13:e14099
33. Tarawneh, O. and Tarawneh, H. (2021) Immune thrombocytopenia in a 22-year-old post Covid-19
vaccine. Am. J. Hematol. 96:E133-E134
34. Tirado, S.M.C. and Yoon, K. (2003) Antibody-dependent enhancement of virus infection and
disease. Viral immunology 16:69-86
35. Tseng, C. et al. (2012) Immunization with SARS coronavirus vaccines leads to pulmonary
immunopathology on challenge with the SARS virus. PLoS One 7:e35421
36. Weingartl, H. et al. (2004) Immunization with modified vaccinia virus Ankara-based recombinant
vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.
J. Virol. 78:12672-6
37. Czub, M. et al. (2005) Evaluation of modified vaccinia virus Ankara based recombinant SARS
vaccine in ferrets. Vaccine 23:2273-9
38. Bolles, M. et al. (2011) A double-inactivated severe acute respiratory syndrome coronavirus
vaccine provides incomplete protection in mice and induces increased eosinophilic
proinflammatory pulmonary response upon challenge. J. Virol. 85:12201-15
39. World Medical Association, (2017) WMA Declaration of Geneva.
 We For Humanity
We are an international association of lawyers, doctors, scientists, journalists as
well as representatives of other professions.
We represent interests of all people in the world who aspire to live in freedom,
self-determination, dignity and truthfulness.

SENT TO:

EMA, EU
MHRA, UK
TGA, Australia,
Medsafe, New Zealand
FMRAC, Canada
AHPRA, Australia

STOP HOLOCAUST
Ladies and Gentlemen,
We, the survivors of the atrocities committed against humanity during the Second World
War, feel bound to follow our conscience and write this letter.
It is obvious to us that another holocaust of greater magnitude is taking place before our
eyes. The majority of the world’s populace do not yet realize what is happening, for
magnitude of an organized crime such as this is beyond their scope of experience. We,
however, know. We remember the name Josef Mengele. Some of us have personal
memories. We experience a déjà vu that is so horrifying that we rise to shield our poor
fellow humans. The threatened innocents now include children, and even infants.

In just four months, the COVID-19 vaccines have killed more people than all available
vaccines combined from mid-1997 until the end of 2013 — a period of 15.5 years. And
people affected worst are between 18 and 64 years old – the group which was not in the
Covid statistics.
We call upon you to stop this ungodly medical experiment on humankind immediately.
What you call "vaccination" against SARS-Cov-2 is in truth a blasphemic encroachment into
nature. Never before has immunization of the entire planet been accomplished by delivering
a synthetic mRNA into the human body. It is a medical experiment to which the Nuremberg
Code must be applied. The 10 ethical principles in this document represents a foundational
code of medical ethics that was formulated during the Nuremberg Doctors Trial to ensure
that human beings will never again be subjected to involuntary medical experimentation &
procedures.
Principle 1 of the Nuremberg Codex:
(a) “The voluntary consent of the human subject is absolutely essential. This
means that the person involved should have legal capacity to give consent; should
be so situated as to be able to exercise free power of choice, without the
intervention of any element of force, fraud, deceit, duress, overreaching, or other
 ulterior form of constraint or coercion; and should have sufficient knowledge and
comprehension of the elements of the subject matter involved as to enable him to
make an understanding and enlightened decision. (b) This latter element requires
that before the acceptance of an affirmative decision by the experimental subject
there should be made known to him the nature, duration, and purpose of the
experiment; the method and means by which it is to be conducted; all
inconveniences and hazards reasonably to be expected; and the effects upon his
health or person which may possibly come from his participation in the experiment.
(c) The duty and responsibility for ascertaining the quality of the consent rests upon
each individual who initiates, directs, or engages in the experiment. It is a personal
duty and responsibility which may not be delegated to another with impunity.
Re. (a): There is no question of a free decision. Mass media spread fear and panic and use
the rule of Goebbels’ propaganda by repeating untruths until they are believed. For weeks
now they have been calling for the ostracism of the unvaccinated. If 80 years ago it was the
Jews who were demonized as spreaders of infectious diseases, today it is the unvaccinated
who are being accused of spreading the virus. Physical integrity, freedom to travel, freedom
to work, all coexistence has been taken away from people in order to force vaccination upon
them. Children are being enticed to get vaccinated against their parents’ judgement.

Re (b): The 22 terrible side effects already listed in the FDA emergency use authorization
were not disclosed to the subjects of the experimental trial. We list those below to the
benefit of the world public.

By definition, there has never been informed consent. In the meantime, thousands of side
effects recorded in numerous databases are on record. While the so-called case numbers are
being bleeped in 30-min-intervals by all mass media, there is neither any mentioning of the
serious adverse side effects nor how and where the side effects are to be reported. As far as
we know, even recorded damages have been deleted on a large scale in every database.
Principle 6 of the Nuremberg Code requires: "The degree of risk to be taken should never
exceed that determined by the humanitarian importance of the problem to be solved by the
experiment".
"Vaccination" against Covid has proven to be more dangerous than Covid for approximately
99% of all humans. As documented by Johns Hopkins, in a study of 48,000 children, children
are at zero risk from the virus. Your own data shows that children who are at no risk from
the virus, have had heart attacks following vaccination; more than 15,000 have suffered
adverse events – including more than 900 serious events. At least 16 adolescents have died
following vaccination in the USA. As you are aware, just around 1% are being reported. And
the numbers are increasing rapidly as we write. With your knowledge.

Principle 10 of the Code: "During the course of the experiment, the scientist in charge must
be prepared to terminate the experiment at any stage, if he has probable cause to believe, in
the exercise of the good faith, superior skill and careful judgment required of him, that a
continuation of the experiment is likely to result in injury, disability, or death to the
experimental subject."
Allegedly around 52% of the world population has received at least one shot.
Honest disclosure of the true number of “vaccine” injured, terminally injured as well as
deceased worldwide is long overdue. These are millions in the meantime. Provide us with
the true numbers of Covid vaccine casualties now.
How many will be enough to awaken your conscience?

List of adverse effects being known to FDA before the emergency approval
1. Guillain-Barré syndrome 12. Deaths
2. Acute disseminated 13. Pregnancy and birth outcomes
encephalomyelitis 14. Other acute demyelinating
3. Transverse myelitis diseases
4. Encephalitis/encephalomyelitis/me 15. Non-anaphylactic allergic reactions
ningoencephalitis/meningitis/ence 16. Thrombocytopenia
pholapathy 17. Disseminated intravascular
5. Convulsions/seizures coagulation
6. Stroke 18. Venous thromboembolism
7. Narcolepsy and cataplexy 19. Arthritis and arthralgia/joint pain
8. Anaphylaxis 20. Kawasaki disease
9. Acute myocardial infraction 21. Multisystem inflammatory
10. Myocarditis/pericarditis syndrome in CHILDREN
11. Autoimmune disease 22. Vaccine enhanced disease.

Signed
Concentration Camp survivors, their sons, and daughters, and grandchildren, including
persons of goodwill and conscience.
According to present consents:

Rabbi Hillel Handler Hila Moscovich

Hagar Schafrir Tamir Turgal

Sorin Shapira Amira Segal

Mascha Orel Jacqueline Ingenhoes
Morry Krispijn Andrea Drescher
Shimon Yanowitz Edgar Siemund, Esq.